# Intermediate-Sized Expanded Access Study

> **NCT05597436** · — · NO_LONGER_AVAILABLE · sponsor: **Seelos Therapeutics, Inc.**

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Trehalose

## Key facts

- **NCT ID:** NCT05597436
- **Lead sponsor:** Seelos Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-09-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05597436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05597436, "Intermediate-Sized Expanded Access Study". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05597436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*